The number of workers in the United States exposed to beryllium vary but has been estimated to be as high as 800,000 during the 1960s and 1970s. A more recent study from 2004 estimated the number of exposed workers in the United States to be around 134,000. The rate of workers becoming sensitized to beryllium varies based on genetics and exposure levels. In one study researchers found the prevalence of beryllium sensitization to range from 9 - 19% depending on the industry. Many workers who are found to be sensitive to beryllium also meet the diagnostic criteria for CBD. In one study of nuclear workers, among those who were sensitized to beryllium, 66% were found to have CBD as well. The rate of progression from beryllium sensitization to CBD has been estimated to be approximately 6-8% per year. Stopping exposure to beryllium in those sensitized has not been definitively shown to stop the progression to CBD. The overall prevalence of CBD among workers exposed to beryllium has ranged from 1 – 5% depending on industry and time period of study. The general population is unlikely to develop acute or chronic beryllium disease because ambient air levels of beryllium are normally very low (3). However, a study found 1% of people living within 3/4 of a mile of a beryllium plant in Lorain, Ohio, had<unk>  after exposure to concentrations estimated to be less than 1 milligram per cubic metre of air. In the United States the Beryllium Case Registry contained 900 records, early cases relating to extraction and fluorescent lamp manufacture, later ones coming from the aerospace, ceramics and metallurgical industries.
Berylliosis
Baritosis
Metastrongylosis
Tungiasis
Acanthocheilonemiasis
Naegleriasis
Necatoriasis
Sulfatidosis